Literature DB >> 2985698

Fine specificities of autoantibodies directed against the Ro, La, Sm, RNP, and Jo-1 proteins defined by two-dimensional gel electrophoresis and immunoblotting.

K B Elkon, P W Jankowski.   

Abstract

Although useful for specific purposes, immunofluorescence, precipitation in agarose gels, and the m.w. estimation of RNA or proteins immunoprecipitated from transformed cells often provide partial or ambiguous definition of autoantibody specificity. We have analyzed organ and cell extracts by one-and two-dimensional electrophoresis together with Western blotting to define the fine specificities of antibodies to the ribonucleoprotein (RNP) antigens Ro, La, Sm, RNP and Jo-1. One-dimensional analysis identified the Ro protein as a 57 kilodalton (kd) protein, although many anti-Ro sera also react with a 50 kd protein. La antisera react with 50 and 43 kd proteins. The 50 kd La protein readily breaks down into 43, 25, and smaller immunoreactive cleavage products. Partial proteolysis of Ro and La proteins in human spleen extracts produces similar immunoreactive products, providing evidence for a common structure. The major immunoreactive Sm antigens defined by human polyclonal antisera and a mouse monoclonal antiserum were doublets of 25/26 and 16/18 kd, whereas anti-RNP sera reacted with a protein of 68 kd. Most Sm-RNP antisera contained antibodies reactive with additional proteins, especially when whole cell extracts were used as a source of antigens. Two-dimensional analysis provided characteristic maps of the antigens. Ro and La were acidic, and La showed a unique set of acidic charge isomers at 50 and 43 kd. Anti-Sm antibodies reacted with discrete dots corresponding to both the acidic and basic regions of the first-dimension (charge) gels, whereas the RNP antigen showed a series of basic charge isomers of 68 kd. Many anti-Sm-RNP sera reacted with other closely spaced proteins of a similar charge and size to the Sm and RNP antigens, suggesting antibody cross-reactivity or reactivity with closely related functional proteins. Although Jo-1 had the same m.w. as the undegraded La antigen, the fingerprints were quite distinctive on two-dimensional electrophoresis. The results of this study indicate how the source and preparation of antigen extracts, as well as protein degradation, influence the m.w. determinations of soluble protein antigens. With these factors taken into account, two-dimensional fractionation with immunoblotting provides a highly discriminating, sensitive, and reproducible method of analysis of autoantibody specificity. This technique can be used to standardize reference antisera and to study protein antigens in normal and abnormal cell and tissue extracts, and could lead to new or more precise correlations with clinical disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985698

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells.

Authors:  F Hiepe; K Yamamoto; A Takeuchi; E Apostoloff; T Miyamoto
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells.

Authors:  M Bachmann; W J Mayet; H C Schröder; K Pfeifer; K H Meyer zum Büschenfelde; W E Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus.

Authors:  K Elkon; S Skelly; A Parnassa; W Moller; W Danho; H Weissbach; N Brot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Comparison between autoantibodies in malaria and leprosy with lupus.

Authors:  E Bonfa; R Llovet; M Scheinberg; J M de Souza; K B Elkon
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

6.  Analysis of autoantibody specificities in selected systemic lupus erythematosus (SLE) sera.

Authors:  A M Francoeur
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

7.  Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease.

Authors:  J W Moll; H Hooijkaas; B C van Goorbergh; L G Roos; S C Henzen-Logmans; C J Vecht
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

8.  Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation.

Authors:  T D Golan; K B Elkon; A E Gharavi; J G Krueger
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients' mononuclear cells.

Authors:  J Magsaam; A E Gharavi; A P Parnassa; H Weissbach; N Brot; K B Elkon
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

Review 10.  Use of synthetic peptides for the detection and quantification of autoantibodies.

Authors:  K B Elkon
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.